DochertyAB, HarrisonEM, GreenCA, HardwickHE, PiusR, NormanL, et al. ISARIC4C investigators. Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO clinical characterization protocol: prospective observational cohort study. BMJ, 2020; 369:m1985.
2.
Ospina-TasconGA, Calderon-TapiaLE, GarciaAF, ZaramaV, Gomez-AlvarezF, Alvarez-SaaT, et al. HiFLo-Covid Investigators. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA, 2021; 326(21):2161-2171.
3.
PerkinsGD, JiC, ConnollyBA, CouperK, LallR, BaillieJK, et al. RECOVERY-RS Collaborators. Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial. JAMA, 2022; 327(6):546-558.
4.
ThompsonAE, RanardBL, WeiY, JelicS. Prone positioning in awake, nonintubated patients with COVID-19 hypoxemic respiratory failure. JAMA Intern Med, 2020; 180(11):1537-1539.
5.
ElharrarX, TriguiY, DolsAM, TouchonF, MartinezS, Prud’hommeE, et al. Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMA, 2020; 323(22):2336-2338.
RocaO, CaraltB, MessikaJ, SamperM, SztrymfB, HernandezG, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med, 2019; 199(11):1368-1376.
8.
FinkDL, GoldmanNR, CaiJ, El-ShakankeryKH, SismeyGE, Gupta-WrightA, et al. Ratio of oxygen saturation index to guide management of COVID-19 pneumonia. Ann Am Thorac Soc, 2021; 18(8):1426-1428.
9.
ZucmanN, MullaertJ, RouxD, RocaO, RicardJD. Contributors. Prediction of outcome of nasal high flow use during COVID-19–related acute hypoxemic respiratory failure. Intensive Care Med, 2020; 46(10):1924-1926.
10.
ChandelA, PatoliaS, BrownAW, CollinsAC, SahjwaniD, KhangooraV, et al. High-flow nasal cannula therapy in COVID-19: using the ROX index to predict success. Respir Care, 2021; 66(6):909-919.
11.
AgarwalA, BasmajiJ, MuttalibF, GrantonD, ChaudhuriD, ChetanD, et al. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth, 2020; 67(9):1217-1248.
12.
FinkJB, EhrmannS, LiJ, DaileyP, McKiernanP, DarquenneC, et al. Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine. J Aerosol Med Pulm Drug Deliv, 2020; 33(6):300-304.
13.
TeliasI, KatiraBH, BrochardL. Is the prone position helpful during spontaneous breathing in patients with COVID-19?. JAMA, 2020; 323(22):2265-2267.
14.
GriecoDL, MengaLS, CesaranoM, RosaT, SpadaroS, BitondoMM, et al. COVID-ICU Gemelli Study Group. Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA, 2021; 325(17):1731-1743.
15.
SartiniC, TresoldiM, ScarpelliniP, TettamantiA, CarcoF, LandoniG, et al. Respiratory parameters in patients with COVID-19 after using noninvasive ventilation in the prone position outside the intensive care unit. JAMA, 2020; 323(22):2338-2340.
